Mergers & Acquisitions
-
2018.07.09
Boston Scientific to Acquire Cryterion Medical
Company to expand atrial fibrillation ablation therapy offerings with innovative cryoballoon platform.
Read More -
2018.07.04
Dare to ‘Dreem’: J&J Invests in Sleep-Focused Medtech Startup
Dreem, a neurotechnology startup developing sleep-related devices, raised $35 million in a round led by Johnson & Johnson’s investment arm.
Read More -
Dare to ‘Dreem’: J&J Invests in Sleep-Focused Medtech Startup
Dreem, a neurotechnology startup developing sleep-related devices, raised $35 million in a round led by Johnson & Johnson’s investment arm.
Read More -
2018.06.04
Combining AI and Wearables to Track Fertility in Women
Ava, a startup, has raised about $30 million in a series B round to expand its bracelet-like technology into other aspects of health in women.
Read More -
2018.03.27
RenovaCare Fights Back Against Alleged ‘Predatory’ Trading
RenovaCare said it has video evidence showing what appears to be predatory trading practices of several FINRA member firms in its stock. The company said the firms may be in cahoots with The Street Sweeper, a short seller syndicate targeting the company.
Read More -
Laborie Set to Acquire Cogentix
Laborie Medical Technologies is poised to get a leg up in the urology market by acquiring Cogentix Medical for about $239 million.
Read More -
Here’s Something for Zimmer Investors to Chew On
According to a Wall Street Journal report, Zimmer Biomet is considering a sale of its dental unit.
Read More -
J&J Acquisition Could Give Stryker a Run for Its Money in Robotics
With Johnson & Johnson’s acquisition of Orthotaxy, it joins a growing list of medtech players seeking to beef up their offerings in the surgical robotics market.
Read More -
Varian to Acquire Embattled Sirtex for $1.3B
Sirtex, which specializes in interventional oncology, suffered numerous setbacks in 2017, including the firing of its CEO and disappointing clinical trial results.
Read More -
Weight-Loss Balloon Maker to Serve Up $35M Offering
Obalon Therapeutics, developer of the first FDA-approved swallowable, gas-filled balloon for obesity treatment, is preparing an underwritten public offering of its common stock.
Read More